Pyrimidinone compounds which are HNE inhibitors
US9868740B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2014 |
| Grant date | Jan 16, 2018 |
| Priority date | — |
| Expiry date | Jun 12, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.